Sinae Vogel

Pre-eclampsia as an etiology for preterm birth: what is the burden of disease?

Objective The authors evaluated the differences in preterm birth rates in the setting of pre-eclampsia by gestational age (GA) at birth and between different racial/ethnic groups. Study Design This is a retrospective cohort study of all pregnant women delivered in California in 2006, separated into two cohorts: pre-eclampsia and no pre-eclampsia. Outcome data were tabulated by four GA groups (24–27, 28–31, 32–36 and 37–42 weeks) and stratified by race/ethnicity. Results Women with pre-eclampsia are at a significantly increased risk of delivering at earlier GAs as compared to women without pre-eclampsia at all GA groups analysed (p<0.001): 24–27 weeks, 0.4% vs 1.4%; 28–31 weeks, 0.8% vs 4.9%; and 32–36 weeks, 9.1% vs 28.2%. Preterm delivery rates in the setting of pre-eclampsia varied by race/ethnicity and were significantly lower in Latinas (p<0.001): 31.4% in Latinas, 37.2% in Caucasians, 38.2% in African Americans and 38.9% in Asians. Conclusion Although African American women without pre-eclampsia experience higher preterm birth rates than other racial/ethnic groups, this effect is not seen in African American women with pre-eclampsia. In the setting of pre-eclampsia, Latinas have fewer preterm births than other racial/ethnic groups.

Low-dose aspirin for prevention of pre-eclampsia and its complications: a cost-effectiveness analysis

Objective The authors investigated whether low-dose aspirin (ASA) is a cost-effective means of reducing the risk of pre-eclampsia. Study Design A decision analytic model was designed comparing ASA prophylaxis vs no prophylaxis in a theoretical cohort of 100 000 pregnant women. Costs and prevalences were derived from existing randomised controlled trails. Utilities were applied to discounted life expectancy to generate quality-adjusted life years (QALYs), which were discounted at 3%. A cost-effectiveness threshold of

Pre-eclampsia as an etiology for preterm birth: what is the burden of disease for twins?

100 000/QALY was utilised. Results ASA prophylaxis is the dominant strategy. It is both cheaper (

592: Treating mild gestational diabetes to improve maternal and neonatal outcomes: a cost effectiveness analysis

18 720 vs

591: Low-dose aspirin for prevention of preeclampsia and its complications: a cost-effectiveness analysis

18 804) and marginally more effective (26.7417 QALYs vs 26.7422 QALYs). Additionally, negative outcomes associated with pre-eclampsia were reduced in the intervention group, most notably fewer preterm births (10 312 vs 10 251). In sensitivity analysis, when the authors varied the efficacy of ASA prophylaxis, it remained cost-effective up to a relative risk of 0.91 for all nulliparous women and 0.98 for women with a 25% risk of pre-eclampsia. Conclusion Low-dose ASA appears to be a cost-effective prophylaxis for pre-eclampsia over a wide range of assumptions, particularly for women at elevated risk for pre-eclampsia. Abstract PM.42 Outcomes for 100,000 Nulliparous Pregnant Women NO ASA ASA Preeclampsia 5000 4150 Preterm Births 103120 10250.5 Neonatal Death 257.1 256.9 Maternal Deaths 13.8 13.1 Neurodevelopmental Disability 370.9 369.7 Costs 51,880,421,000 51,871,989,000 QALYs 2674174.1 2674224.

650: Cost-effectiveness of prenatal HIV screening strategies in Uganda

Objective The authors evaluated the differences in twin preterm birth rates in the setting of pre-eclampsia by gestational age at birth and between different racial/ethnic groups. Abstract PM.50 Study Design This is a retrospective cohort study of women pregnant with twins delivered in California in 2006, separated into two cohorts: pre-eclampsia and no pre-eclampsia. Outcome data were tabulated by four gestational age groups (24–27, 28–31, 32–36 and 37–42 weeks) and stratified by race/ethnicity. Results Women with pre-eclampsia are at a significantly increased risk of delivering at 32–36 weeks as compared to women without pre-eclampsia (p<0.001): 61.4% vs 45.5%. Preterm delivery rates in the setting of pre-eclampsia varied by race/ethnicity and were significantly higher in Caucasians and lower in Asians (p<0.001): 71.0% in Caucasians, 66.7% in African Americans, 67.0% in Latinas and 63.6% in Asians. Conclusion Women with twins who also have pre-eclampsia have 15.9% more preterm births. Although African American women without pre-eclampsia experience higher preterm birth rates than other racial/ethnic groups, this effect is not seen in African American women with pre-eclampsia. In the setting of pre-eclampsia, Caucasians have more and Asians have fewer preterm births than other racial/ethnic groups.